How about Shaanxi Nippon Pharmaceutical Co., Ltd.?

Xi Anlibang Enterprise, founded in 1996, is an enterprise group with high-tech biomedical industry as the leading factor, integrating research and development, production and sales of pharmaceutical products, and also involved in nutrition industry and cultural industry.

With xi Libang Enterprise Investment Co., Ltd. as the parent company, Libang Enterprise has seven wholly-owned and holding subsidiaries, including Xi Libang Pharmaceutical Co., Ltd., Xi Libang Pharmaceutical Distribution Co., Ltd., Libang Canada University Co., Ltd., Xi Libang Clinical Nutrition Co., Ltd., Shaanxi Kangzheng Co., Ltd. and Xi Libang Art and Culture Investment Co., Ltd., with a total of nearly 1,000 employees.

As a high-tech enterprise, Nippon has a high-level and high-quality scientific research team composed of doctors and masters. Based on R&D centers in China and Canada, it cooperates closely with many medical research institutions at home and abroad and actively carries out related R&D activities. At present, it is the national liposome industrialization demonstration engineering base and Shaanxi liposome engineering technology center, and has achieved fruitful results in the research and development and application of liposomes, fat emulsions, microemulsions and drug-loaded microspheres, with strong industrialization capabilities. From 65438 to 0999, Nippon took the lead in developing propofol injection "Limengxin" and won the "Queen Award" in China. It is still the most ideal anesthetic preparation, ranking first in the domestic propofol market for many years, and the share of domestic hospitals exceeds 40%.

Libang's three major pharmaceutical industry production bases cover a total area of nearly 60,000 square meters, and many production lines have been built, such as small-volume injections, large-volume injections, freeze-dried powder injections, oral liquids, solid preparations and related raw materials, all of which have passed GMP certification and some have passed FDA certification, with the total number of varieties exceeding 100, forming three major product series of narcotic drugs, nutritional drugs and cardiovascular and cerebrovascular drugs.

Nippon is committed to creating "three good" products with good curative effect, good quality and good service with core competitiveness, and has formed "three major systems" of marketing services for decision-making, promotion and implementation. The marketing network covers more than 6,000 medical institutions in 3/kloc-0 provinces, laying a solid foundation for Libang's brand building and sustainable development.

From 65438 to 0999, Xi Anlibang Clinical Nutrition Co., Ltd., the first domestic enterprise engaged in the research, development, production and operation of clinical enteral nutrition products, was established, and a series of clinical nutritional products were developed, mainly including "Lishikang" enteral nutrition products, maternal nutrition products and sports nutrition products such as whey protein powder, glutamine, myogenic powder and branched-chain amino acids specially developed for bodybuilders to meet the differentiated needs of different groups for nutritional products.

Xi Anlibang Art and Culture Investment Co., Ltd. mainly focuses on overseas cultural relics such as porcelain, calligraphy and painting, jade, bronzes and miscellaneous items, and also involves contemporary calligraphy and painting, high-end works of art originals and replicas. It is currently the largest comprehensive cultural industry group in Xi High-tech Zone.

In the new era, faced with new opportunities and challenges, Libang people are adhering to the corporate mission of "advocating science and making all beings healthy", carrying forward the entrepreneurial spirit of "self-improvement and teamwork", pioneering and innovating in the direction of specialization, standardization, scale and internationalization, striving to achieve a new leap, striving to continue to write new glories, and determined to make new and greater contributions to the cause of human health.

/